Epigenetic alterations of tumor marker microRNAs: Towards new cancer therapies

Drug News and Perspectives

Volumn 23, Issue 10, 2010, Pages 655-661

  Wei, Jia ^a   Xie, Li ^a   Taron, Miquel ^b   Rosell, Rafael ^b   Liu, Baorui ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 PHENYLBUTYRIC ACID; 5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; AZACITIDINE; FLUOROURACIL; IRINOTECAN; LOCKED NUCLEIC ACID; MICRORNA; SMALL INTERFERING RNA; TOPOTECAN; TUMOR MARKER;

ADVANCED CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER INVASION; CANCER RESEARCH; CANCER STAGING; CANCER THERAPY; COLON CANCER; EPIGENETICS; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MYELODYSPLASTIC SYNDROME; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER; ANIMAL; DRUG DELIVERY SYSTEM; GENETIC EPIGENESIS; GENETICS; METABOLISM; NEOPLASM;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; EPIGENESIS, GENETIC; HUMANS; MICRORNAS; NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79954441594     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2010.23.10.1560143     Document Type: Review

References (104)

1. Griffiths-Jones, S., Saini, H.K., van Dongen, S., Enright, A.J. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008, 36(Database issue): D154-8.
2. Lee, R.C., Feinbaum, R.L., Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5): 843-54.
3. Malumbres, R., Sarosiek, K.A., Cubedo, E. et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009, 113(16): 3754-64.
4. Mascaux, C., Laes, J.F., Anthoine, G., Haller, A., Ninane, V., Burny, A., Sculier, J.P. Evolution of microRNA expression during human bronchial squamous carcinogenesis. Eur Respir J 2009, 33(2): 352-9.
5. Tong, A.W., Fulgham, P., Jay, C. et al. MicroRNA profile analysis of human prostate cancers. Cancer Gene Ther 2009, 16(3): 206-16.
6. Yan, L.X., Huang, X.F., Shao, Q. et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 2008, 14(11): 2348-60.
7. Lytle, J.R., Yario, T.A., Steitz, J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 2007, 104(23): 9667-72.
8. Lee, I., Ajay, S.S., Yook, J.I. et al. New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites. Genome Res 2009, 19(7): 1175-83.
9. Qin, W., Shi, Y., Zhao, B., Yao, C., Jin, L., Ma, J., Jin, Y. miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells. PLoS One 2010, 5(2): e9429.
10. Lewis, B.P., Burge, C.B., Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120(1): 15-20.
11. Xie, X., Lu, J., Kulbokas, E.J. et al. Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature 2005, 434(7031): 338-45.
12. Friedman, R.C., Farh, K.K., Burge, C.B., Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2009, 19(1): 92-105.
13. Vasudevan, S., Tong, Y., Steitz, J.A. Switching from repression to activation: microRNAs can up-regulate translation. Science 2007, 318(5858): 1931-4.
14. Zhang, B., Farwell, M.A. microRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med 2008, 12(1): 3-21.
15. Hwang, H.W., Mendell, J.T. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006, 94(6): 776-80.
16. Esquela-Kerscher, A., Slack, F.J. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006, 6(4): 259-69.
17. Calin, G.A., Dumitru, C.D., Shimizu, M. et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002, 99(24): 15524-9.
18. Volinia, S., Calin, G.A., Liu, C.G. et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103(7): 2257-61.
19. He, L., Thomson, J.M., Hemann, M.T. et al. A microRNA polycistron as a potential human oncogene. Nature 2005, 435(7043): 828-33.
20. O'Donnell, K.A., Wentzel, E.A., Zeller, K.I., Dang, C.V., Mendell, J.T. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435(7043): 839-43.
21. Hayashita, Y., Osada, H., Tatematsu, Y. et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005, 65(21): 9628-32.
22. Childs, G., Fazzari, M., Kung, G. et al. Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma. Am J Pathol 2009, 174(3): 736-45.
23. Lawrie, C.H., Gal, S., Dunlop, H.M. et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141(5): 672-5.
24. Kong, W., He, L., Coppola, M., Guo, J., Esposito, N.N., Coppola, D., Cheng, J.Q. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010, 285(23): 17869-79.
25. Huang, Q., Gumireddy, K., Schrier, M. et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10(2): 202-10.
26. Yan, H.J., Wu, J.X., Liu, W.S. et al. MicroRNA-20a overexpression inhibited proliferation and metastasis of pancreatic carcinoma cells. Hum Gene Ther 2010, Advance publication.
27. Tavazoie, S.F., Alarcon, C., Oskarsson, T. et al. Endogenous human microRNAs that suppress breast cancer metastasis. Nature 2008, 451(7175): 147-52.
28. Johnson, S.M., Grosshans, H., Shingara, J. et al. RAS is regulated by the let-7 microRNA family. Cell 2005, 120(5): 635-47.
29. Slaby, O., Svoboda, M., Fabian, P. et al. Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology 2007, 72(5-6): 397-402.
30. Petrocca, F., Visone, R., Onelli, M.R. et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008, 13(3): 272-86.
31. Visone, R., Petrocca, F., Croce, C.M. Micro-RNAs in gastrointestinal and liver disease. Gastroenterology 2008, 135(6): 1866-9.
32. Roldo, C., Missiaglia, E., Hagan, J.P. et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006, 24(29): 4677-84.
33. Murakami, Y., Yasuda, T., Saigo, K., Urashima, T., Toyoda, H., Okanoue, T., Shimotohno, K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006, 25(17): 2537-45.
34. Iorio, M.V., Visone, R., Di Leva, G. et al. MicroRNA signatures in human ovarian cancer. Cancer Res 2007, 67(18): 8699-707.
35. Mitchell, P.S., Parkin, R.K., Kroh, E.M. et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105(30): 10513-8.
36. Chen, X., Ba, Y., Ma, L. et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18(10): 997-1006.
37. Szafranska, A.E., Davison, T.S., Shingara, J. et al. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. J Mol Diagn 2008, 10(5): 415-23.
38. Lu, J., Getz, G., Miska, E.A. et al. MicroRNA expression profiles classify human cancers. Nature 2005, 435(7043): 834-8.
39. Rosenfeld, N., Aharonov, R., Meiri, E. et al. MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol 2008, 26(4): 462-9.
40. Lebanony, D., Benjamin, H., Gilad, S. et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from non-squamous non-small-cell lung carcinoma. J Clin Oncol 2009, 27(12): 2030-7.
41. Wang, C.J., Zhou, Z.G., Wang, L. et al. Clinicopathological significance of microRNA-31, -143 and -145 expression in colorectal cancer. Dis Markers 2009, 26(1): 27-34.
42. Calin, G.A., Ferracin, M., Cimmino, A. et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353(17): 1793-801.
43. Yanaihara, N., Caplen, N., Bowman, E. et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9(3): 189-98.
44. Bloomston, M., Frankel, W.L., Petrocca, F. et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297(17): 1901-8.
45. Chen, Y., Stallings, R.L. Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis. Cancer Res 2007, 67(3): 976-83.
46. Markou, A., Tsaroucha, E.G., Kaklamanis, L., Fotinou, M., Georgoulias, V., Lianidou, E.S. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem 2008, 54(10): 1696-704.
47. Schetter, A.J., Leung, S.Y., Sohn, J.J. et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008, 299(4): 425-36.
48. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S.T., Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133(2): 647-58.
49. Zhu, S., Si, M.L., Wu, H., Mo, Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 2007, 282(19): 14328-36.
50. Frankel, L.B., Christoffersen, N.R., Jacobsen, A., Lindow, M., Krogh, A., Lund, A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008, 283(2): 1026-33.
51. Yu, S.L., Chen, H.Y., Chang, G.C. et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13(1): 48-57.
52. Johnson, C.D., Esquela-Kerscher, A., Stefani, G. et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007, 67(16): 7713-22.
53. Mayr, C., Hemann, M.T., Bartel, D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007, 315(5818): 1576-9.
54. Lee, Y.S., Dutta, A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 2007, 21(9): 1025-30.
55. Viswanathan, S.R., Powers, J.T., Einhorn, W. et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009, 41(7): 843-8.
56. Wang, Y.C., Chen, Y.L., Yuan, R.H., Pan, H.W., Yang, W.C., Hsu, H.C., Jeng, Y.M. Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis 2010, 31(9): 1516-22.
57. Hermeking, H. p53 enters the microRNA world. Cancer Cell 2007, 12(5): 414-8.
58. Bommer, G.T., Gerin, I., Feng, Y. et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 2007, 17(15): 1298-307.
59. Tsujiura, M., Ichikawa, D., Komatsu, S. et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 2010, 102(7): 1174-9.
60. Hu, Z., Chen, X., Zhao, Y. et al. Serum microRNA signatures identified in a genomewide serum microRNA expression profiling predict survival of non-small-cell lung cancer. J Clin Oncol 2010, 28(10): 1721-6.
61. Link, A., Balaguer, F., Shen, Y., Nagasaka, T., Lozano, J.J., Boland, C.R., Goel, A. Fecal MicroRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev 2010, 19(7): 1766-74.
62. Mishra, P.J., Bertino, J.R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009, 10(3): 399-416.
63. Jazdzewski, K., Murray, E.L., Franssila, K., Jarzab, B., Schoenberg, D.R., de la Chapelle, A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2008, 105(20): 7269-74.
64. Shen, J., Ambrosone, C.B., DiCioccio, R.A., Odunsi, K., Lele, S.B., Zhao, H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008, 29(10): 1963-6.
65. Boni, V., Zarate, R., Villa, J.C. et al. Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J 2010, Advance publication.
66. Visone, R., Croce, C.M. MiRNAs and cancer. Am J Pathol 2009, 174(4): 1131-8.
67. Tili, E., Michaille, J.J., Gandhi, V., Plunkett, W., Sampath, D., Calin, G.A. miRNAs and their potential for use against cancer and other diseases. Future Oncol 2007, 3(5): 521-37.
68. Wu, W. MicroRNA: Potential targets for the development of novel drugs? Drugs R D 2010, 10(1): 1-8.
69. Lu, Y., Xiao, J., Lin, H., Bai, Y., Luo, X., Wang, Z., Yang, B. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res 2009, 37(3): e24.
70. Fabbri, M., Garzon, R., Cimmino, A. et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007, 104(40): 15805-10.
71. Duursma, A.M., Kedde, M., Schrier, M., le Sage, C., Agami, R. miR-148 targets human DNMT3b protein coding region. RNA 2008, 14(5): 872-7.
72. Benetti, R., Gonzalo, S., Jaco, I. et al. A mammalian microRNA cluster controls DNA methylation and telomere recombination via Rbl2-dependent regulation of DNA methyltransferases. Nat Struct Mol Biol 2008, 15(3): 268-79.
73. Han, L., Witmer, P.D., Casey, E., Valle, D., Sukumar, S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther 2007, 6(8): 1284-8.
74. Saito, Y., Liang, G., Egger, G., Friedman, J.M., Chuang, J.C., Coetzee, G.A., Jones, P.A. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006, 9(6): 435-43.
75. Lehmann, U., Hasemeier, B., Christgen, M., Muller, M., Romermann, D., Langer, F., Kreipe, H. Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 2008, 214(1): 17-24.
76. Fazi, F., Racanicchi, S., Zardo, G. et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell 2007, 12(5): 457-66.
77. Kozaki, K., Imoto, I., Mogi, S., Omura, K., Inazawa, J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008, 68(7): 2094-105.
78. Meng, F., Wehbe-Janek, H., Henson, R., Smith, H., Patel, T. Epigenetic regulation of microRNA-370 by interleukin-6 in malignant human cholangiocytes. Oncogene 2008, 27(3): 378-86.
79. Grady, W.M., Parkin, R.K., Mitchell, P.S. et al. Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene 2008, 27(27): 3880-8.
80. Lu, L., Katsaros, D., de la Longrais, I.A., Sochirca, O., Yu, H. Hypermethylation of let- 7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Cancer Res 2007, 67(21): 10117-22.
81. Bandres, E., Agirre, X., Bitarte, N. et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer 2009, 125(11): 2737-43.
82. Roman-Gomez, J., Agirre, X., Jimenez-Velasco, A. et al. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia. J Clin Oncol 2009, 27(8): 1316-22.
83. Agirre, X., Vilas-Zornoza, A., Jimenez-Velasco, A. et al. Epigenetic silencing of the tumor suppressor microRNA Hsa-miR-124a regulates CDK6 expression and confers a poor prognosis in acute lymphoblastic leukemia. Cancer Res 2009, 69(10): 4443-53.
84. Lee, K.H., Lotterman, C., Karikari, C. et al. Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology 2009, 9(3): 293-301.
85. Scott, G.K., Mattie, M.D., Berger, C.E., Benz, S.C., Benz, C.C. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006, 66(3): 1277-81.
86. Saito, Y., Suzuki, H., Tsugawa, H., Nakagawa, I., Matsuzaki, J., Kanai, Y., Hibi, T. Chromatin remodeling at Alu repeats by epigenetic treatment activates silenced microRNA-512-5p with downregulation of Mcl-1 in human gastric cancer cells. Oncogene 2009, 28(30): 2738-44.
87. Noonan, E.J., Place, R.F., Pookot, D. et al. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer. Oncogene 2009, 28(14): 1714-24.
88. Mack, G.S. Epigenetic cancer therapy makes headway. J Natl Cancer Inst 2006, 98(20): 1443-4.
89. Garzon, R., Volinia, S., Liu, C.G. et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008, 111(6): 3183-9.
90. Christensen, B.C., Moyer, B.J., Avissar, M. et al. A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis 2009, 30(6): 1003-7.
91. Chang, K.W., Liu, C.J., Chu, T.H., Cheng, H.W., Hung, P.S., Hu, W.Y., Lin, S.C. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma. J Dent Res 2008, 87(11): 1063-8.
92. Qian, B., Katsaros, D., Lu, L. et al. High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1. Breast Cancer Res Treat 2009, 117(1): 131-40.
93. Camps, C., Buffa, F.M., Colella, S. et al. hsamiR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008, 14(5): 1340-8.
94. Hu, Z., Chen, J., Tian, T. et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008, 118(7): 2600-8.
95. Takamizawa, J., Konishi, H., Yanagisawa, K. et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004, 64(11): 3753-6.
96. Guo, Y., Chen, Z., Zhang, L. et al. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res 2008, 68(1): 26-33.
97. Bandres, E., Bitarte, N., Arias, F. et al. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin Cancer Res 2009, 15(7): 2281-90.
98. Motoyama, K., Inoue, H., Takatsuno, Y. et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009, 34(4): 1069-75.
99. Xi, Y., Formentini, A., Chien, M., Weir, D.B., Russo, J.J., Ju, J., Kornmann, M. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2006, 2: 113-21.
100. Diaz, R., Silva, J., Garcia, J.M. et al. Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer 2008, 47(9): 794-802.
101. Li, W., Xie, L., He, X. et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008, 123(7): 1616-22.
102. Jiang, J., Gusev, Y., Aderca, I. et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008, 14(2): 419-27.
103. Budhu, A., Jia, H.L., Forgues, M. et al. Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008, 47(3): 897-907.
104. Nam, E.J., Yoon, H., Kim, S.W. et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 2008, 14(9): 2690-5.